| |
| |
|
| Insider
Information: |
Ramos Eleanor |
| Relationship: |
Chief Medical Officer |
| City: |
Seattle |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
14,970 |
|
|
Indirect Shares
|
1,000 |
|
|
| Direct
Value |
$854,070 |
|
|
|
Indirect Value
|
$68,490 |
|
|
| Total
Shares |
15,970 |
|
|
| Total
Value |
$922,560 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
3
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-3.0
|
0.0
|
| Percentage
Gain/Loss : |
 -29.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Zymogenetics Inc |
ZGEN |
Sr. VP, Chief Medical ... |
2010-10-08 |
2,500 |
|
0 |
Premium* |
|
|
Global Blood Therapeutics, Inc. |
GBT |
Chief Medical Officer |
2016-02-01 |
12,470 |
2016-02-01 |
1,000 |
Premium* |
|
|
Provention Bio Inc |
PRVB |
Chief Medical Officer |
2023-04-27 |
0 |
2018-07-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PRVB |
Provention Bio Inc |
Chief Medical Officer |
• – – |
2023-04-27 |
4 |
D |
$0.00 |
$0 |
D/D |
(70,000) |
0 |
0 |
- |
|
| PRVB |
Provention Bio Inc |
Chief Medical Officer |
• – – |
2021-12-03 |
4 |
B |
$6.49 |
$33,765 |
D/D |
5,201 |
70,000 |
2.74 |
% |
|
| PRVB |
Provention Bio Inc |
Chief Medical Officer |
• – – |
2020-09-02 |
4 |
B |
$12.06 |
$3,606 |
D/D |
299 |
64,799 |
2.66 |
% |
|
| PRVB |
Provention Bio Inc |
Chief Medical Officer |
• – – |
2020-08-20 |
4 |
B |
$13.23 |
$33,075 |
D/D |
2,500 |
64,500 |
2.74 |
% |
|
| PRVB |
Provention Bio Inc |
CMO & COO |
• – – |
2019-12-26 |
4 |
B |
$14.34 |
$28,680 |
D/D |
2,000 |
62,000 |
2.74 |
- |
|
| PRVB |
Provention Bio Inc |
Chief Medical Officer & COO |
• – – |
2018-07-19 |
4 |
B |
$4.00 |
$240,000 |
D/D |
60,000 |
60,000 |
2.74 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Medical Officer |
• – – |
2016-02-01 |
4 |
A |
$16.09 |
$23,652 |
D/D |
1,470 |
12,470 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Medical Officer |
• – – |
2015-12-22 |
4 |
B |
$30.28 |
$30,280 |
D/D |
1,000 |
11,000 |
2.74 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Medical Officer |
• – – |
2015-08-17 |
4/A |
B |
$20.00 |
$20,000 |
I/I |
1,000 |
1,000 |
1.99 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Medical Officer |
• – – |
2015-08-17 |
4 |
B |
$20.00 |
$200,000 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
| ZGEN |
Zymogenetics Inc |
Sr. VP, Chief Medical Officer |
• – – |
2010-10-08 |
4 |
D |
$9.75 |
$35,090 |
D/D |
(3,599) |
2,500 |
0 |
- |
|
| ZGEN |
Zymogenetics Inc |
Sr. VP, Chief Medical Officer |
• – – |
2010-02-24 |
4 |
S |
$5.66 |
$3,747 |
D/D |
(662) |
6,099 |
0 |
- |
|
| ZGEN |
Zymogenetics Inc |
Sr. VP, Chief Medical OfficerO |
• – – |
2009-06-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,761 |
|
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
